Lexology (registration) Rodrigues arose out of a case in multidistrict litigation (“MDL”) concerning heparin , a drug commonly used to reduce the risk of blood clots. In the MDL case, the district court ruled that the admissible expert testimony supported only claims in which ...
The Oncology Report MADRID – The selective factor Xa inhibitor fondaparinux was as effective as low-molecular-weight heparin in preventing venous thromboembolism following resection of esophageal cancer in a prospective, randomized trial. Deep vein thrombosis was ...
The Herald | HeraldOnline.com (press release) Global Market Report of Heparin sodium (CAS 9041-08-1) aims at providing comprehensive data on Heparin sodium globally and regionally (Europe, Asia, North America, Latin America etc.). It captures Heparin sodium trends, pays close attention to Heparin ... and more »
News-Medical.net Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin , a century-old injectable drug that thins the blood to prevent clots from forming. The study, conducted in mice and published ...
Healio Patients who received inferior vena cava filter without heparin after total joint arthroplasty experienced significantly lower complication rates compared with patients who received both inferior vena cava filter and inferior vena heparin , according to ...
ShareCast Shares in Akers Biosciences were higher on news that it had secured a major distribution agreement in the US for its test to determine if patients will have a reaction to blood thinner heparin . The company's PIFA Heparin /PF4 and PIFA PLUSS PF4 rapid ...
Drug Discovery & Development Researchers at Duke Medicine have identified a new strategy for treating neuroblastoma using a modified version of heparin , a century-old injectable drug that thins the blood to prevent clots from forming. The study, conducted in mice and published in ... and more »
GMA News June 26, 2014 9:45pm. After tagging contaminated heparin as the cause of chills experienced by some patients at the National Kidney and Transplant Institute last May, Philippine health authorities have issued an advisory against two brands of the product.
